Trial Profile
Comparative antiplatelet effects of pretreatment clopidogrel versus prasugrel in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 May 2014
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Acute coronary syndromes; Myocardial infarction
- Focus Pharmacodynamics
- 19 May 2014 New trial record